[go: up one dir, main page]

FI952803A0 - Bensazepinonderivat - Google Patents

Bensazepinonderivat

Info

Publication number
FI952803A0
FI952803A0 FI952803A FI952803A FI952803A0 FI 952803 A0 FI952803 A0 FI 952803A0 FI 952803 A FI952803 A FI 952803A FI 952803 A FI952803 A FI 952803A FI 952803 A0 FI952803 A0 FI 952803A0
Authority
FI
Finland
Prior art keywords
bensazepinonderivat
Prior art date
Application number
FI952803A
Other languages
English (en)
Finnish (fi)
Other versions
FI952803A7 (sv
Inventor
Peter Buehlmayer
Pascal Furet
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of FI952803A0 publication Critical patent/FI952803A0/sv
Publication of FI952803A7 publication Critical patent/FI952803A7/sv
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI952803A 1992-12-11 1995-12-06 Bensazepinonderivat FI952803A7 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH380192 1992-12-11
PCT/EP1993/003426 WO1994013651A1 (de) 1992-12-11 1993-12-06 Benzazepinon-derivate

Publications (2)

Publication Number Publication Date
FI952803A0 true FI952803A0 (sv) 1995-06-07
FI952803A7 FI952803A7 (sv) 1995-06-07

Family

ID=4263742

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952803A FI952803A7 (sv) 1992-12-11 1995-12-06 Bensazepinonderivat

Country Status (11)

Country Link
US (1) US5610153A (sv)
EP (1) EP0673371A1 (sv)
JP (1) JPH08505374A (sv)
KR (1) KR950704280A (sv)
AU (1) AU685768B2 (sv)
CA (1) CA2151384A1 (sv)
FI (1) FI952803A7 (sv)
HU (1) HUT72330A (sv)
NO (1) NO952288D0 (sv)
NZ (1) NZ258889A (sv)
WO (1) WO1994013651A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines
EP0833819B1 (en) * 1995-06-07 2003-03-26 Merck & Co., Inc. Novel n-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
EP2298298A3 (en) 1998-12-23 2011-05-11 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
US6211217B1 (en) 1999-03-16 2001-04-03 Novartis Ag Method for reducing pericardial fibrosis and adhesion formation
GB9914745D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US7291639B2 (en) * 2001-06-20 2007-11-06 Wyeth Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
KR100710547B1 (ko) * 2002-01-02 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
KR100710548B1 (ko) 2002-12-26 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
US12161649B2 (en) 2018-06-21 2024-12-10 Dana-Farber Cancer Institute, Inc. Inhibitors of EGFR and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072352B1 (de) * 1981-08-11 1986-03-05 Ciba-Geigy Ag Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4477464A (en) * 1983-02-10 1984-10-16 Ciba-Geigy Corporation Hetero-benzazepine derivatives and their pharmaceutical use
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO952288L (no) 1995-06-09
AU685768B2 (en) 1998-01-29
US5610153A (en) 1997-03-11
WO1994013651A1 (de) 1994-06-23
NO952288D0 (no) 1995-06-09
FI952803A7 (sv) 1995-06-07
HUT72330A (en) 1996-04-29
CA2151384A1 (en) 1994-06-23
EP0673371A1 (de) 1995-09-27
KR950704280A (ko) 1995-11-17
AU5696794A (en) 1994-07-04
HU9501693D0 (en) 1995-08-28
JPH08505374A (ja) 1996-06-11
NZ258889A (en) 1997-02-24

Similar Documents

Publication Publication Date Title
FI943521A0 (sv) Sacral-implantsystem
FI930554A0 (fi) Organopolysiloxanbaserade loesgoeringskompositioner foer papper
DE59303358D1 (de) Quaterrylentetracarbonsäureimide
DE59306810D1 (de) Gutbettwalzenmühle
DE59302851D1 (de) Sportschuh
BR9305745A (pt) Quebra-luz
DE59301902D1 (de) Kassenlade
DE59305364D1 (de) Rotornut
FIU920051U0 (fi) Krossanordning
FI943342A0 (fi) Poroes skivmaterial
FI952803A0 (sv) Bensazepinonderivat
DE69304512D1 (de) Laseroszillator
DE69306208D1 (de) Ablenkjoch
DE59304139D1 (de) Polyanile
NO180477C (no) Hövel
FI932406L (fi) Stoedbalk foer en bestrykningsanordning
DE59309200D1 (de) Bisphosphinoalkane
DE59301762D1 (de) Chlorethylsulfonylbenzaldehyde
NO931004L (no) 6-klorpikolinsyreklorid
FI903U1 (fi) Saollskovel
DE59206388D1 (de) Kabeleckkanal
BR9200298A (pt) Microsisten-telesupervisao
BR9200296A (pt) Varre-lava
BR9200611A (pt) Hidrocofre
BR7200318U (pt) Cabide sanfonado

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed